Gillson Sciences Expands into Environmental Health with SanAir Acquisition

Gillson Sciences has announced the acquisition of SanAir Technologies Laboratory, Inc., an accredited environmental testing and consulting laboratory.

The move marks a strategic expansion beyond life sciences testing into environmental health, reflecting Gillson’s broader focus on human health across the full risk continuum.

Why this acquisition matters?

Human health is shaped long before clinical intervention. Environmental factors: air, water, food systems, and built environments, play a critical role in disease prevention and long-term outcomes.

By adding environmental testing capabilities, Gillson Sciences is positioning itself earlier in the health lifecycle. The acquisition strengthens Gillson’s mission to prevent, protect, and defend against disease, not just detect it.

Strategic rationale

“This acquisition strengthens our commitment to advancing public health and safety,” said Jason Fischer, CEO of Gillson Sciences. “Health is influenced not only by clinical care, but by the environments in which people live, work, and eat. SanAir allows us to apply the same scientific rigor we bring to life sciences testing to environmental health risks.”

What SanAir brings to the platform?

SanAir adds decades of expertise and a strong reputation for accuracy, reliability, and client-focused service. Its core capabilities include environmental testing and consulting across:

• Air quality, including VOCs and soil vapor intrusion
• LEED, WELL, IAQP, and IgCC certification systems
• Industrial hygiene and biogas testing
• Asbestos analysis
• Environmental microbiology and bacteria testing
• Lead and heavy metals
• Material science
• Legionella and other environmental hazards

These services align directly with Gillson’s science-driven approach to protecting human health.

Continuity for existing clients

SanAir will continue to operate under its existing brand name during the integration period.

This ensures uninterrupted service while giving clients access to Gillson Sciences’ broader resources, innovation capabilities, and global reach.

Leadership perspective from SanAir

“Joining Gillson Sciences allows us to scale our impact and expand our service offerings,” said Sean McGlynn, President of SanAir. “Together, we are positioned to set new standards in environmental testing and consulting while continuing to deliver the trusted expertise our clients rely on.”

A unified health sciences platform

Post-acquisition, the combined organization supports clients across:

• Health and life sciences
• Nutritional science
• Environmental science

All under a shared mission: advancing and protecting human health.

The transaction reinforces Gillson Sciences’ long-term growth strategy and strengthens its position in environmental health and safety services.

About Gillson Sciences

Headquartered in Chicago, Illinois, Gillson Sciences delivers laboratory testing, environmental testing, and scientific advisory solutions.

The company combines deep scientific expertise with advanced technology to help organizations reduce risk, navigate complexity, and accelerate progress—across both life sciences and environmental health.

About SanAir Technologies Laboratory

Based in Richmond, Virginia, SanAir provides accredited analytical and consulting services in environmental testing.

Its portfolio spans air quality, microbiology, metals, asbestos, industrial hygiene, and other environmental hazards, serving clients nationally and internationally.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!